← Insider buys

Kenneth Michael Reali has bought BVS on 2 days since Feb 2021

CEO at Bioventus Inc.

SEC CIK 0001480801 · Filings on SEC.gov ↗

$149KBought
$0Sold
Sep 10Last buy

Kenneth Michael Reali's record

3 months after each buy, from the first price a copier could get.

No buys have 3 months of prices yet. A record shows here at 3.

Every filing

2 filings since Apr 2021, newest first

About Kenneth Michael Reali

Kenneth Michael Reali is a medical device executive and corporate insider who has served as Chief Executive Officer of Bioventus Inc. (BVS), a company focused on orthobiologic solutions for bone healing and musculoskeletal conditions.( He was appointed CEO of Bioventus in April 2020, having previously led Clinical Innovations, LLC, a women’s health–focused medical device company, and has executed leadership roles across several medtech firms including Biomet, Stryker, Smith & Nephew, and Baxano Surgical.( During his tenure at Bioventus he reported transactions in company stock as CEO, as reflected in SEC Form 4 filings.(

Reali’s nearly three-decade career in the medical device industry spans product development, global marketing, commercialization, reimbursement strategy, and regulatory and clinical affairs.( He has served on the boards of Ossio Integrative Orthopedics, AdvaMed, and AdvaMed Accel, where he chaired the Ethics and Compliance Committee, and later continued his portfolio career as a corporate board chair and independent director in medtech companies.( Reali holds a Bachelor’s degree in Business Administration from Valparaiso University, providing the business foundation for his executive roles and board service in the healthcare technology sector.(

Written by Perplexity from public sources.

Filings come from SEC EDGAR. Not investment advice.